Ceramic implants come of age
Prof. Holst explores the development of ceramic implants, and how Nobel Biocare now offers a unique solution giving clinicians peace of mind in a niche, yet growing market.
The author serves as Vice President, Global Research, Products and Marketing at Nobel Biocare headquarters in Zurich, Switzerland. Both an experienced clinician and a teacher, he is an adjunct professor at the University of Pennsylvania and an associate professor at the University of Frankfurt.
Here, Professor Holst explores the development of ceramic implants, and how Nobel Biocare now offers a unique solution that can give clinicians peace of mind in this niche, yet growing market.
More than ten years ago, Nobel Biocare sponsored clinical trials of a potential product that was not brought to market. Those trials generated neither the data nor the clinical outcomes we require.4 But over the interceding decade our body of knowledge has grown substantially and researchers with whom we collaborate have now reached the point where we can provide a zirconia implant that is designed to work reliably.